Literature DB >> 11840838

Lycopene supplementation attenuates the inflammatory status of colitis in a rat model.

R Reifen1, T Nur, Z Matas, Z Halpern.   

Abstract

The aim of this study was to examine the influence of lycopene and beta-carotene on the inflammatory status in a rat model of induced-colitis. Using the 2,4,6-trinitrobenzenesulfonic acid (TNBS) model, colitis was induced in thirty-two male Wistar rats divided into four groups. Each group received a different diet regime in parallel with the induction of colitis and was sacrificed after seven days. The groups were divided as follows: Group A: without colitis and fed a normal chow diet; Group B: induced with colitis and fed a diet supplemented with lycopene (300 micrograms/rat/day); Group C: induced with colitis and fed a diet supplemented with beta-carotene (300 micrograms/rat/day); Group D: induced with colitis and fed a normal chow diet. Colonic inflammation following TNBS induction was characterized by hemorrhagic necrosis and fibrosis of the mucosa, increased colonic wall thickness, infiltration of inflammatory cells, and increased myeloperoxidase (MPO) activity. Supplementation of lycopene in the diet had a beneficial effect on the various macroscopic parameters examined including: colonic thickness, colon weight, and total area of inflammation. Furthermore, the level of myeloperoxidase (MPO) was significantly lower in the lycopene-treated group compared to the control group. In terms of microscopic changes, a more attenuated inflammatory reaction was observed in the group fed a diet supplemented with lycopene. No significant effect was noted in the beta-carotene-supplemented group. Therefore, we propose that the dietary supplementation of lycopene may be an effective approach for reducing the level of oxidative stress and improving the inflammatory status of colitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11840838     DOI: 10.1024/0300-9831.71.6.347

Source DB:  PubMed          Journal:  Int J Vitam Nutr Res        ISSN: 0300-9831            Impact factor:   1.784


  6 in total

1.  Barrier protective effects of lycopene in human endothelial cells.

Authors:  Jae Woan Bae; Jong-Sup Bae
Journal:  Inflamm Res       Date:  2011-04-13       Impact factor: 4.575

Review 2.  Dietary factors in the modulation of inflammatory bowel disease activity.

Authors:  Shinil Shah
Journal:  MedGenMed       Date:  2007-03-27

3.  Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-kappaB in macrophages.

Authors:  Dan Feng; Wen-Hua Ling; Rui-Dong Duan
Journal:  Inflamm Res       Date:  2009-08-20       Impact factor: 4.575

4.  Stimulation of deep somatic tissue with capsaicin produces long-lasting mechanical allodynia and heat hypoalgesia that depends on early activation of the cAMP pathway.

Authors:  K A Sluka
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

5.  Anti-inflammatory effect of lycopene in SW480 human colorectal cancer cells.

Authors:  Jae Hoon Cha; Woo Kyoung Kim; Ae Wha Ha; Myung Hwan Kim; Moon Jeong Chang
Journal:  Nutr Res Pract       Date:  2017-02-15       Impact factor: 1.926

6.  Lycopene modulates THP1 and Caco2 cells inflammatory state through transcriptional and nontranscriptional processes.

Authors:  Njock Makon-Sébastien; Fouchier Francis; Seree Eric; Villard Pierre Henri; Landrier Jean François; Pechere Laurent; Barra Yves; Champion Serge
Journal:  Mediators Inflamm       Date:  2014-05-07       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.